Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension: a randomized, controlled trial

Article Abstract:

Increased intake of fish oil by hypertensive people to lower blood pressure and fat levels may not cause glucose intolerance. Researchers compared the effect of a daily, 16-week treatment with n-3 polyunsaturated fatty acids, as found in fish oil, with placebo in 78 people with hypertension. Fish oil treatment lowered blood pressure and fat levels without affecting glucose tolerance or insulin secretion or resistance. Patients with the lowest levels of fish oil acids in the blood experienced the greatest reductions in blood pressure. Patients with the highest blood fat levels experienced the greatest reductions in fat levels. None of the patients had diabetes, therefore study results may not be directly applicable to diabetics.

Hypertension, Physiological aspects, Diet therapy, Glucose metabolism

---

The Effect of Dietary [Omega]-3 Fatty Acids on Coronary Atherosclerosis

Article Abstract:

Fish oil supplements may modestly alter the progression of coronary artery disease. Consumption of fish containing high levels of omega-3 fatty acids may have a beneficial effect on heart disease. Researchers evaluated angiographic examinations in 223 patients before and after they supplemented their diet with fish oil or placebo capsules. In two years, patients taking fish oil supplements had slightly less progression of the narrowing of their coronary arteries.

United States, Coronary heart disease, Atherosclerosis

---

Similar abstracts:

• Abstracts: Fish oil supplementation does not lower plasma cholesterol in men with hypercholesterolemia. Can the hypotriglyceridemic effect of fish oil concentrate be sustained?
• Abstracts: A mixed Australian fish diet and fish-oil supplementation: impact on the plasma lipid profile of healthy men. Energy supplementation and the nutritional status of hemodialysis patients
• Abstracts: Criteria for recognition of the growth-inefficient child who may respond to treatment with growth hormone. part 2
• Abstracts: Spontaneous resolution of bone mineral depletion in preterm infants. Bone mineral content and body size 65 to 100 weeks' postconception in preterm and full term infants
• Abstracts: Where to draw the line against cholesterol. Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.